10 Recruiting Lymphoma Clinical Trials in California
Explore active lymphoma research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceRecruiting Lymphoma Studies in California
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
📍 UC San Diego Moores Cancer Center — La Jolla, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell Lymphoma
📍 Stanford Cancer Institute — Stanford, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma
📍 City of Hope Comprehensive Cancer Center — Duarte, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Interventional Protocol 📊 Observational Clinical Research
Navigating the Clinical Research Process for Lymphoma
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas
📍 Stanford Medicine Cancer Center — Palo Alto, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
📍 Research Site — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase3 💊 Investigational Drug / Biologic
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
📍 Alta Bates Summit Medical Center — Berkeley, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy
📍 Stanford — Stanford, California
View Study & Checklist ➔ 🟢 Recruiting Interventional Protocol 📊 Observational Clinical Research
Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy
📍 Children s Hospital of Los Angeles — Los Angeles, California
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)
📍 Stanford Medical Center — Stanford, California
View Study & Checklist ➔